Microvascular Regeneration
Safely restore the tiny vessels that feed every tissue
The goal is to safely regenerate the microvasculature — the smallest blood vessels (capillaries) that deliver oxygen to every cell — restoring the fine circulation that disease and aging erode, with no new health problems. This page maps each pathway with the science behind it.
Beyond the large arteries lies the microvasculature: billions of capillaries so fine that red cells pass single-file, delivering oxygen to every tissue. Much of the damage in diabetes, kidney disease, and aging is microvascular — the slow loss of these tiny vessels, starving tissue from within. The same vessel-growing biology that builds large vessels rebuilds small ones, and supporting it restores the fine circulation tissue depends on. Each pathway below names its science and stage.
We are building the capability to safely regenerate the microvasculature: supporting capillary growth, protecting the vessel-lining cells that build them, and restoring the fine circulation that disease erodes — so tissue is re-supplied at the smallest scale.
Each regeneration pathway — capability, science, and stage
Supporting capillary growth Demonstrated — clinical
The science: the body grows new capillaries throughout life via angiogenesis; physical activity is among the strongest stimulators of capillary growth in muscle and tissue. Supporting this native microvessel-building is the most grounded route, linked to muscle and whole-body fitness.
Protecting the capillary lining Demonstrated — clinical
The science: capillaries are almost entirely endothelium — vessel lining; protecting it (see vessel-wall repair) is the heart of microvascular health. Healthy blood sugar is critical, since high glucose damages capillaries first.
Restoring microcirculation in tissue Clinical
Why it matters: restoring the microvasculature restores tissue oxygenation — protecting the kidneys, eyes, nerves, and other tissues that microvascular disease silently starves.
Stimulating microvascular angiogenesis Clinical / Frontier
The science: therapeutic angiogenesis aims to regrow capillary networks in tissue that has lost them, delivering the body’s own pro-growth signals — an emerging strategy advancing through research toward people.
Mobilizing vessel-builder cells Frontier
The work: endothelial progenitor cells contribute to building new capillaries; research is advancing their use to restore microvascular networks. Promising, with human results still mostly ahead, and labeled frontier.
Restoring oxygen delivery, not just vessels Clinical / Frontier
The north star: success means tissue actually receives oxygen again — measured as restored perfusion and tissue health. Genuine microcirculatory recovery, achieved safely, is the measure of success.
Cited as evidence the capability is real — not as partners or endorsers.
Government & programs
the National Heart, Lung, and Blood Institute (NHLBI, NIH) and the American Heart Association, which fund microvascular and angiogenesis research (all mechanisms).
Angiogenesis & capillary researchers
Groups studying capillary growth, exercise-driven angiogenesis, and therapeutic microvascular angiogenesis (mechanisms 1, 4).
Endothelial & progenitor-cell researchers
Researchers advancing endothelial repair and EPC-driven capillary growth (mechanisms 2, 5).
Enabling science
capillary and angiogenesis biology · endothelial repair · endothelial progenitor cells · microvascular physiology · tissue perfusion measurement.
The technologies: capillary-growth support (grounded, available today through activity and healthy blood sugar), endothelial protection, therapeutic microvascular angiogenesis (advancing toward people), and the frontier of progenitor-cell regeneration — together aiming to restore the fine circulation tissue depends on.
The body grows new capillaries Demonstrated — clinical
Capillary growth via angiogenesis occurs throughout life and is strongly stimulated by activity — the grounded basis of microvascular regeneration.
Blood sugar protects the small vessels Demonstrated — clinical
High blood sugar damages capillaries first; protecting healthy blood sugar is central to microvascular health.
Microvascular angiogenesis is advancing Clinical / Frontier
Regrowing capillary networks in tissue that lost them is an emerging strategy moving through research.
Vessel-builder cells help Frontier
Endothelial progenitor cells contribute to new capillaries — promising, with human results still mostly ahead.
The honest challenges: microvascular regeneration is real but partly early. Capillary growth through activity and protected blood sugar is genuine and available today, but stimulated and cell-based microvascular regeneration are still largely at the research stage. Restoring lost microvasculature in damaged tissue is not yet routine. We are honest about that. But the direction is real: the fine circulation that disease erodes is becoming something we can begin to rebuild, with no new health problems.
The future, fully built
A future where the smallest vessels can be safely regrown: capillary growth supported, the lining protected, microcirculation restored, and — as the frontier matures — microvascular networks rebuilt. The slow starvation of microvascular disease becomes something we can reverse, re-supplying tissue at the smallest scale.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Capillary angiogenesisDemonstrated (clinical)
The body grows new capillaries throughout life; physical activity is among the strongest stimulators of capillary growth in tissue.
Blood sugar & capillariesDemonstrated (clinical)
High blood sugar damages capillaries first; protecting healthy blood sugar is central to microvascular health.
Therapeutic microvascular angiogenesisClinical / Frontier
Regrowing capillary networks in tissue that lost them by delivering pro-growth signals; an emerging strategy advancing through research.
Endothelial progenitor cellsFrontier
EPCs contribute to building new capillaries; research is advancing their use to restore microvascular networks, with human results mostly ahead.
Tissue perfusionClinical
Restoring microvasculature restores tissue oxygenation — protecting kidneys, eyes, nerves, and other tissues microvascular disease starves.
Honest framing
Real organizations and research findings are cited as evidence the capability is real — not as partners or endorsers. The Healthy capability is the safe protection and restoration of healthy blood vessels, creating no new health problems.
Help build this future
Every signature grows the movement to make safe microvascular regeneration real — and free at the point of need.